Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone

Published:2024-05 Issue:5 Volume:38 Page:108741
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Filardi Tiziana,Feraco Alessandra,Ouvrard-Pascaud Antoine,Rizzo Manfredi,Caprio Massimiliano

Funder

Ministero della Salute

Publisher

Elsevier BV

Reference23 articles.

1. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis;Fox;Lancet,2012

2. Diabetic kidney disease: a report from an ADA Consensus Conference;Tuttle;Diabetes Care,2014

3. Advances in the pharmacological management of diabetic nephropathy: a 2022 international update;Giglio;Biomedicines,2023

4. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease;Kidney Disease: Improving Global Outcomes Diabetes Work Group;Kidney Int,2022

5. 11. Chronic kidney disease and risk management: standards of care in diabetes-2023;ElSayed;Diabetes Care,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP